Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

537.13 -7.32 (-1.34%)
Official Closing Price Updated: 7:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,971,612
Open 545.49
Bid (Size) 533.00 (1)
Ask (Size) 541.00 (1)
Prev. Close 544.45
Today's Range 532.20 - 546.09
52wk Range 302.14 - 601.84
Shares Outstanding N/A
Dividend Yield 0.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What A Government Shutdown Could Mean For You
In a nail-biting development amid fears of a government shutdown, the House has passed a bipartisan bill, narrowly averting the blackout as the midnight deadline looms. 
Via Benzinga
These 5 Stocks Are Setting Up This Buying Opportunity After Strong Runs
Stocks can offer a new buying opportunity with a pullback to the 50-day line. 
Via Investor's Business Daily

Performance

YTD
+47.16%
+47.16%
1 Month
-3.08%
-3.08%
3 Month
+16.41%
+16.41%
6 Month
+53.14%
+53.14%
1 Year
+66.11%
+66.11%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Shares of Structure Therapeutics Are Soaring on Friday
Via The Motley Fool
Newcomer Structure Throws Down The Gauntlet In Obesity Treatment -- Shares Soar 66%
Via Investor's Business Daily
Check Out What Whales Are Doing With LLY
Via Benzinga
Eli Lilly Unusual Options Activity For September 25
Via Benzinga
Eli Lilly, Former Employee Settle Lawsuit Concerning Manufacturing Dispute
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle
Via Investor's Business Daily
After Achieving 100% Cancer Remission Rates In Preclinical Studies, Starpax Magnetodrones Head For Human Trials
Via News Direct
Topics Death
Exposures Death
3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals
Via InvestorPlace
Despite Being Costly, Ozempic, Wegovy Prescriptions Surge 300% Over Three Years
Via Benzinga
Diabetes Prevalence Continues To Rise – Better Therapeutics' Digital Treatment Could Help Change This Trajectory
Via Benzinga
Popular Weight Loss Drugs Ozempic and Wegovy Alert: FDA Adds Intestinal Blockage Warning
Via Benzinga
Exposures Product Safety
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
Via Benzinga
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Weight Loss Drugs Like Wegovy Could Have Linked Anesthesia Complications, European Medicines Agency To Investigate
Via Benzinga
Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Three Of Our Top Picks For Your Healthcare Portfolio
Via Talk Markets
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
Via InvestorPlace
2 Magnificent Dividend Stocks to Buy Right Now
Via The Motley Fool
3 Artificial Intelligence (AI) Stocks That Could Soar More Than Nvidia, According to Wall Street
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Magnificent Growth Stocks to Buy Right Now
Via The Motley Fool
David vs. Goliath: 3 Stocks Poised to Challenge the ‘Magnificent 7′
Via InvestorPlace
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.